NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

eVusheld Assessment reaL wORld Effectiveness at UPMC

CompletedN/A

Sponsor: AstraZeneca

Conditions: SARS-CoV-2, COVID-19

Interventions: EVUSHELD

Countries: United States

An AstraZeneca-sponsored observational, electronic healthcare record (EHR)-embedded retrospective cohort study to assess the real-world effectiveness of EVUSHELD against SARS-CoV-2 infection, COVID-19-related hospitalization, and other COVID-19 related outcomes in the total EUA-eligible patient population in the University of Pittsburgh Medical Center (UPMC) Health System.

Eligibility overview

Sex: ALL

Age: 12 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Receipt of EVUSHELD under the FDA EUA for EVUSHELD
2. Eligibility for assess Evusheld use under the EUA. -

Exclusion Criteria:

* None

Locations (1)

Pittsburgh, Pennsylvania, United States